Cue Biopharma Market Sentiment

Cue Biopharma Inc

CUENASDAQ

$20.87

-0.58-2.7%

Últ. Act.: Oct 29, 4:25 PM

Cue Biopharma Market Sentiment - Benzinga

Market sentiment signals for Cue Biopharma (CUE): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 11.5% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

8 analysts

Options Flow (P/C)

—

Avg Consensus PT

$127

+490.3%

Highest Price Target

$300

+1298.6%

Oppenheimer

Lowest Price Target

$60

+179.7%

Citizens Capital Markets

Short Interest

11.5%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 18, 2026	B. Riley Securities	Mayank Mamtani—	+286.9%	$83	Initiate	Buy
Aug 25, 2025	LUCID CAPITAL MARKETS	Dev Prasad —	+459.4%	$120	Initiate	Buy
Apr 2, 2025	Citizens Capital Markets	Reni Benjamin—	+179.7%	$60 → $60	Maintained	Market Outperform
Aug 20, 2024	Stifel	Stephen Willey—	+459.4%	$240 → $120	Maintained	Buy
Jul 26, 2024	JMP Securities	Reni Benjamin—	+179.7%	$450 → $60	Maintained	Market Outperform
Jul 26, 2024	Piper Sandler	Edward Tenthoff—	+319.6%	$240 → $90	Maintained	Overweight
Apr 9, 2024	Stifel	Stephen Willey—	+1018.9%	$240 → $240	Maintained	Buy
Apr 9, 2024	Oppenheimer	Leland Gershell—	+1298.6%	$300 → $300	Maintained	Outperform
Apr 3, 2024	Piper Sandler	Edward Tenthoff—	+1018.9%	$240 → $240	Maintained	Overweight
Mar 13, 2024	Jefferies	Maury Raycroft—	+739.2%	$180	Initiate	Buy
Nov 6, 2023	Piper Sandler	Edward Tenthoff—	+1018.9%	$210 → $240	Maintained	Overweight